P807: CLASS Ⅱ FERROPTOSIS INDUCERS ARE A NOVEL THERAPEUTIC APPROACH FOR T (4; 14)-POSITIVE MULTIPLE MYELOMA

J Zhang, Y Liu, L Zuo, F Fan, H Yan, F Zhao… - …, 2023 - journals.lww.com
Background: Multiple myeloma (MM) is characterized by genetic heterogeneity. The
cytogenetic abnormality t (4; 14) strongly predicts poor outcomes in MM patients. MM SET …
相关文章

[引用][C] P807: CLASS Ⅱ FERROPTOSIS INDUCERS ARE A NOVEL THERAPEUTIC APPROACH FOR T (4; 14)‐POSITIVE MULTIPLE MYELOMA

J Zhang, Y Liu, L Zuo, F Fan, H Yan, F Zhao… - …, 2023 - Wiley Online Library
Background: Multiple myeloma (MM) is characterized by genetic heterogeneity. The
cytogenetic abnormality t (4; 14) strongly predicts poor outcomes in MM patients. MM SET …

P807: CLASS Ⅱ FERROPTOSIS INDUCERS ARE A NOVEL THERAPEUTIC APPROACH FOR T (4; 14)-POSITIVE MULTIPLE MYELOMA

J Zhang, Y Liu, L Zuo, F Fan, H Yan, F Zhao… - …, 2023 - ncbi.nlm.nih.gov
Background: Multiple myeloma (MM) is characterized by genetic heterogeneity. The
cytogenetic abnormality t (4; 14) strongly predicts poor outcomes in MM patients. MM SET …

P807: CLASS Ⅱ FERROPTOSIS INDUCERS ARE A NOVEL THERAPEUTIC APPROACH FOR T (4; 14)-POSITIVE MULTIPLE MYELOMA

J Zhang, Y Liu, L Zuo, F Fan, H Yan, F Zhao, B Zhang… - …, 2023 - europepmc.org
Background: Multiple myeloma (MM) is characterized by genetic heterogeneity. The
cytogenetic abnormality t (4; 14) strongly predicts poor outcomes in MM patients. MM SET …